TYRA - Definitive Healthcare rises 45% on public debut; adding to a list of strong healthcare IPOs

Continuing the trend of solid IPO performances in the healthcare sector today, Definitive Healthcare (DH +47.7%) has surged over 40% on its public debut following a public offering of ~15.6 million shares priced at $27.00 apiece. Definitive Healthcare began trading at about 12.25 PM EST at $37.25 per share, implying a premium of ~38.0% to the IPO price. Shortly after, the shares gained another ~7.5% to reach $40.03, indicating a ~48.3% premium to the IPO price. The Framingham, MA-based company offers a healthcare commercial intelligence platform, and initially, it planned to raise $318.9 million in net proceeds, assuming an IPO price of $22.50 per share at the mid-point of the targeted $21 and $24 range. Earlier in the day, two other healthcare companies, Tyra Biosciences (NASDAQ:TYRA) and Procept BioRobotics (NASDAQ:PRCT), made strong performances on their first day of trading.

For further details see:

Definitive Healthcare rises 45% on public debut; adding to a list of strong healthcare IPOs